26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

B lymphocyte antigen receptor (BCR) complex 96 B lymphocyte receptor<br />

and be activated by T cells at extrafollicular sites where the<br />

T cells are present in association with antigen-presenting<br />

dendritic cells. Activated B cells enter the follicles, proliferate,<br />

and displace resting cells. They form germinal centers<br />

and differentiate into both plasma cells that form antibody<br />

and long-lived memory B cells. Those B cells synthesizing<br />

antibodies provide defense against microorganisms including<br />

bacteria and viruses. Surface and cytoplasmic markers reveal<br />

the stage of development and function of lymphocytes in the<br />

B cell lineage. Pre-B cells contain cytoplasmic immunoglobulins,<br />

whereas mature B cells express surface immunoglobulin<br />

and complement receptors. B lymphocyte markers include<br />

CD9, CD19, CD20, CD24, Fc receptors, B1, BA-1, B4, and<br />

Ia. Refer also to B cells.<br />

B lymphocyte antigen receptor (BCR) complex<br />

A B lymphocyte surface multiprotein complex that identifies<br />

antigen and transduces activating signals into cells.<br />

The BCR comprises membrane immunoglobulin that binds<br />

antigen and Igα and Igβ proteins that initiate signals.<br />

B lymphocyte chemokine (BLC)<br />

A CXC chemokine that induces B lymphocytes and activated<br />

T cells to enter peripheral lymphoid tissue follicles by<br />

binding to the CXCR5 receptor.<br />

Schematic representation of immunoglobulin (Ig) on a cell membrane.<br />

Making of a hybridoma for monoclonal antibody production.<br />

B lymphocyte hybridoma<br />

A clone formed by the fusion of a B lymphocyte with a<br />

myeloma cell. Activated splenic B lymphocytes from a specifically<br />

immune mouse are fused with myeloma cells by<br />

polyethylene glycol. Thereafter, the cells are plated in HAT<br />

medium in tissue culture plates containing multiple wells.<br />

The only surviving cells are the hybrids, as the myeloma<br />

cells employed are deficient in HAT medium and fail to<br />

grow in HAT medium. Wells with hybridomas are screened<br />

for antibody synthesis. This is followed by cloning carried<br />

out by limiting the dilution or in soft agar. The hybridomas<br />

are maintained either in tissue culture or through inoculation<br />

into the peritoneal cavity of a mouse that corresponds<br />

genetically to the cell strain. The antibody-producing<br />

B lymphocyte confers specificity and the myeloma cell<br />

confers immortality upon the hybridoma. B lymphocyte<br />

hybridomas produce monoclonal antibodies.<br />

B lymphocyte receptor<br />

Immunoglobulin anchored to the B lymphocyte surface. Its<br />

combination with antigen leads to B lymphocyte division<br />

and differentiation into memory cells, lymphoblasts, and<br />

plasma cells. The original antigen specificity of the immunoglobulin<br />

is maintained in the antibody molecules subsequently<br />

produced. B lymphocyte receptor immunoglobulins

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!